Judge tries to broker treatment deal for patients with macular degeneration in funding row.
Dyer
Clare
C
D000911:Antibodies, Monoclonal / Q000191:economics / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D005381:Financing, Organized / Q000331:legislation & jurisprudence*; D006801:Humans; D007883:Legislation, Medical; D008131:London; D008268:Macular Degeneration / Q000188:drug therapy* / Q000191:economics; D000069579:Ranibizumab
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000069579:Ranibizumab